Involvement of mutations in the DPC4 promoter in endometrial carcinoma development

Molecular Carcinogenesis

Volumn 25, Issue 1, 1999, Pages 64-72

  Zhou, Yong ^a   Kato, Hidenori ^a   Shan, Dan ^a   Minami, Rieko ^b   Kitazawa, Sohei ^b   Matsuda, Takao ^a   Arima, Takahiro ^a   Barrett, J Carl ^c   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

18q loss of heterozygosity; c EBP ; GATA 2; Loss of DPC4 transcription

Indexed keywords

ARTICLE; CANCER GENETICS; CARCINOGENESIS; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; BASE SEQUENCE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 18; CLONING, MOLECULAR; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HETEROZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SEQUENCE TAGGED SITES; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032936925     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199905)25:1<64::AID-MC8>3.0.CO;2-Z     Document Type: Article

References (39)

1. Yamada H, Wake N, Fujimoto S, Barrett JC, Oshimura M. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer. Oncogene 1990;5: 1141-1147.
2. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. The clinico-pathological significance of K-RAS point mutation and gene amplification in endometrial cancer. Eur J Cancer 1997;33:1572-1577.
3. Jones MW, Kounelis S, Hsu C, et al. Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: A clinicopathologic and molecular comparison. Int J Gynecol Pathol 1997;16:354-360.
4. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecol Oncol 1992;47:179-185.
5. Kowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ. Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer 1997;18:219-227.
6. Imamura T, Arima T, Kato H, Miyamoto S, Sasazuki T, Wake N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer 1992;51:47-52.
7. Riggins GJ, Thiagalingam S, Rozenblum E, et al. Mad-related genes in the human. Nat Genet 1996;13:347-349.
8. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-353.
9. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
10. Gima T, Kato H, Honda T, Imamura T, Sasazuki T, Wake N. DCC gene alteration in human endometrial carcinomas. Int J Cancer 1994;57:480-485.
11. Lei J, Zou TT, Shi YQ, et al. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms Oncogene 1996;13:2459-2462.
12. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996;56:2527-2530.
13. Moskaluk CA, Hruban RH, Schutte M, et al. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma. Diagn Mol Path 1997;6:85-90.
14. Kim SK, Fan Y, Papadimitrakopoulou V, et al. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 1996;56:2519-2521.
15. Barrett MT, Schutte M, Kern SE, Reid BJ. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 1996;56:4351-4353.
16. Nagatake M, Takagi Y, Osada H, et al. Somatic in vivo alteration of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 1996;56:2718-2720.
17. Nishizuka S, Tamura G, Maesawa C, et al. Analysis of the DPC4 gene in gastric carcinoma. Jpn J Cancer Res 1997; 88:335-339.
18. Hoque ATMS, Hahn SA, Schutte M, Kern SE. DPC4 gene mutation in colitis associated neoplasia. Gut 1997;40:120-122.
19. Takagi Y, Kohmura H, Futamura M, et al. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 1996;111:1369-1372.
20. Honda T, Kato H, Imamura T, et al. Involvement of p53 gene mutations in human endometrial carcinomas. Int J Cancer 1993;53:963-967.
21. Minami R, Kitazawa R, Maeda S, Kitazawa S. Analysis of 5′ flanking region of Smad4 (DPC4) gene. Biochimica et Biophysica Acta-Gene Structure and Expression 1998;1443:182-185.
22. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991;5:1538-1552.
23. Natsuka S, Akira S, Nishio Y, et al. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 1992;79:460-466.
24. Pope RM, Leutz A, Ness SA. C/EBPβ regulation of the tumor necrosis factor a gene. J Clin Invest 1994;94:1449-1455.
25. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1b gene. Mol Cell Biol 1994;14:7285-7297.
26. Metz R, Ziff E. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 1991;5:1754-1766.
27. Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev 1990;4:1650-1662.
28. Friedman AD, Landschutz WH, McKnight SL. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev 1989; 3:1314-1322.
29. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992;4:575-581.
30. Leonard MW, Brice M, Engel JD, Papayannopoulou T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 1993;82:1071-1079.
31. Briegel K, Lim K-C, Plank C, Beug H, Engel JD, Zenke M. Ectopic expression of a conditional GATA-2/estrogen receptor chimer arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 1993;7:1097-1109.
32. Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ. Characterization of the human platelet/endothelial cell adhesion molecule 1 promoter: Identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 1997;89:1260-1269.
33. Ludlow LB, Schick BP, Budarf ML, et al. Identification of a mutation in a GATA binding site of the platelet glycoprotein lbbeta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996;271:22076-22080.
34. Aird WC, Parvin JD, Sharp PA, Rosenberg RD. The interaction of GATA-binding proteins and basal transcription factors with GATA box-containing core promoters. J Biol Chem 1994; 269:883-889.
35. Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood 1997;89:176-182.
36. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci U S A 1995;92:4462-4466.
37. Kretzschmar M, Liu F, Hata A, Doody J, Massague J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997;11:984-995.
38. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J. Partnership between DPC4 and SMAD proteins in TGFb signalling pathways. Nature 1996;383:832-836.
39. Bergman CA, Talavera F, Christman GM, Baker W, Roberts JA, Menon KM. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A. Gynecol Oncol 1997;65:63-68.